Researchers have launched a national study to see how common the potentially fatal bacterial infection Group B streptococcus is in UK and Irish babies.
Group B Streptococcus (GBS) is a bacterium that can cause serious infections. It is the most important cause of invasive infections in newborn infants and of meningitis in the first three months of life.
Experts at St George's, University of London, in collaboration with the British Paediatric Surveillance Unit and Public Health England will coordinate the study across UK and Ireland which will run for a 13-month period from April 1.
While most infected babies can be treated successfully and will make a full recovery, approximately 10% of babies with GBS disease will die and neurodisability occurs in up to 50% of survivors of GBS meningitis.
Antibiotics given intravenously to the mother during labour may prevent GBS disease in the first week; national guidelines introduced in 2003 and updated in 2012 currently recommend this for women with certain risk factors.
Currently there is no strategy to prevent disease which happens after the first week of life. A vaccine against GBS has been developed and is currently being tested in pregnant women.
The aim of the surveillance study, funded by a grant from the Meningitis Now charity, is to establish the number of cases of GBS in babies aged less than three months of age over a 13 month period.
Comparison with the last national surveillance for GBS, which was 13 years ago, will indicate whether current prevention strategies including the recently updated guidelines have had an impact on the number of cases.
Knowledge of the current situation will also be important for the implementation of a GBS vaccine programme.
Professor Paul Heath, who is leading the study, said: "GBS remains a major health burden. Since our last study 13 years ago around 8,000 babies are likely to have had this infection. Prevention is vital. A promising vaccine is on the horizon which makes this new study even more important."
Clinicians and microbiologists are asked to report cases from 1April 2014 onwards. Clinicians in the UK and Republic of Ireland will be asked to report cases via the BPSU orange card system. Microbiologists and laboratory staff will be requested to notify invasive GBS cases, and submit the isolates, to their national reference laboratory (e.g. PHE).
Clinicians in the Republic of Ireland will also report cases to the Health Protection Surveillance Centre (HPSC) as invasive GBS is a notifiable disease in Ireland. Clinicians in Northern Ireland will also report cases to the Public Health Agency.
Medical Xpress on facebook
Related Stories
More accurate diagnostic test may reduce deaths
Jun 26, 2012
A more accurate, faster diagnostic test for Group B Streptococcal infection in babies has been reported in the Journal of Medical Microbiology. The new test could allow better treatment and management of the disease and re ...
Group B streptococcal meningitis has long-term effects on children's developmental outcomes
Jun 12, 2012
Parents of infants who survive bacterial meningitis caused by group B Streptococcus might have to live with the effects of the disease on their children long after they're discharged from the hospital.
Third trimester group B streptococcus test doesn't accurately predict presence during labor
Feb 11, 2011
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that many women are having different ...
Researchers say more rapid test for Group B strep successful
Mar 08, 2013
A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to the results of a study from The University ...
Progress made on group B streptococcus vaccine
Oct 30, 2009
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus ...
Recommended for you
Five new Ebola cases in Guinea in 24 hours
1 hour ago
Five new cases of the deadly Ebola virus have been recorded in Guinea in the past 24 hours, the World Health Organization said Wednesday.
Guinea's Ebola victims wait for death
5 hours ago
Isolated from the outside world in a medical centre in Ebola-hit southern Guinea, victims of one of the deadliest viruses known to mankind wait listlessly for the merciful release of death.
New FRAX App launched by the International Osteoporosis Foundation
5 hours ago
Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...
Outcomes of administering blood transfusions to patients with lower levels of hemoglobin
17 hours ago
Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated ...
Got acne? There's an App for that
19 hours ago
Acne sufferers around the world are using an iPhone app created at Northwestern University to learn how certain foods affect their skin conditions.
Saudi halts Guinea, Liberia pilgrim visas over Ebola
21 hours ago
Saudi Arabia on Tuesday announced the suspension of visas for Muslim pilgrims from Guinea and Liberia, two African countries hit by an outbreak of the deadly Ebola epidemic.
User comments
© Medical Xpress 2011-2014, Science X network
Researchers have launched a national study to see how common the potentially fatal bacterial infection Group B streptococcus is in UK and Irish babies.
Group B Streptococcus (GBS) is a bacterium that can cause serious infections. It is the most important cause of invasive infections in newborn infants and of meningitis in the first three months of life.
Experts at St George's, University of London, in collaboration with the British Paediatric Surveillance Unit and Public Health England will coordinate the study across UK and Ireland which will run for a 13-month period from April 1.
While most infected babies can be treated successfully and will make a full recovery, approximately 10% of babies with GBS disease will die and neurodisability occurs in up to 50% of survivors of GBS meningitis.
Antibiotics given intravenously to the mother during labour may prevent GBS disease in the first week; national guidelines introduced in 2003 and updated in 2012 currently recommend this for women with certain risk factors.
Currently there is no strategy to prevent disease which happens after the first week of life. A vaccine against GBS has been developed and is currently being tested in pregnant women.
The aim of the surveillance study, funded by a grant from the Meningitis Now charity, is to establish the number of cases of GBS in babies aged less than three months of age over a 13 month period.
Comparison with the last national surveillance for GBS, which was 13 years ago, will indicate whether current prevention strategies including the recently updated guidelines have had an impact on the number of cases.
Knowledge of the current situation will also be important for the implementation of a GBS vaccine programme.
Professor Paul Heath, who is leading the study, said: "GBS remains a major health burden. Since our last study 13 years ago around 8,000 babies are likely to have had this infection. Prevention is vital. A promising vaccine is on the horizon which makes this new study even more important."
Clinicians and microbiologists are asked to report cases from 1April 2014 onwards. Clinicians in the UK and Republic of Ireland will be asked to report cases via the BPSU orange card system. Microbiologists and laboratory staff will be requested to notify invasive GBS cases, and submit the isolates, to their national reference laboratory (e.g. PHE).
Clinicians in the Republic of Ireland will also report cases to the Health Protection Surveillance Centre (HPSC) as invasive GBS is a notifiable disease in Ireland. Clinicians in Northern Ireland will also report cases to the Public Health Agency.
Medical Xpress on facebook
Related Stories
More accurate diagnostic test may reduce deaths
Jun 26, 2012
A more accurate, faster diagnostic test for Group B Streptococcal infection in babies has been reported in the Journal of Medical Microbiology. The new test could allow better treatment and management of the disease and re ...
Group B streptococcal meningitis has long-term effects on children's developmental outcomes
Jun 12, 2012
Parents of infants who survive bacterial meningitis caused by group B Streptococcus might have to live with the effects of the disease on their children long after they're discharged from the hospital.
Third trimester group B streptococcus test doesn't accurately predict presence during labor
Feb 11, 2011
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that many women are having different ...
Researchers say more rapid test for Group B strep successful
Mar 08, 2013
A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to the results of a study from The University ...
Progress made on group B streptococcus vaccine
Oct 30, 2009
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus ...
Recommended for you
Five new Ebola cases in Guinea in 24 hours
1 hour ago
Five new cases of the deadly Ebola virus have been recorded in Guinea in the past 24 hours, the World Health Organization said Wednesday.
Guinea's Ebola victims wait for death
5 hours ago
Isolated from the outside world in a medical centre in Ebola-hit southern Guinea, victims of one of the deadliest viruses known to mankind wait listlessly for the merciful release of death.
New FRAX App launched by the International Osteoporosis Foundation
5 hours ago
Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...
Outcomes of administering blood transfusions to patients with lower levels of hemoglobin
17 hours ago
Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated ...
Got acne? There's an App for that
19 hours ago
Acne sufferers around the world are using an iPhone app created at Northwestern University to learn how certain foods affect their skin conditions.
Saudi halts Guinea, Liberia pilgrim visas over Ebola
21 hours ago
Saudi Arabia on Tuesday announced the suspension of visas for Muslim pilgrims from Guinea and Liberia, two African countries hit by an outbreak of the deadly Ebola epidemic.
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment